BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33183733)

  • 41. New Classification for Central Nervous System Tumors: Implications for Diagnosis and Therapy.
    Fuller CE; Jones DTW; Kieran MW
    Am Soc Clin Oncol Educ Book; 2017; 37():753-763. PubMed ID: 28561665
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Update on diagnostic practice: tumors of the nervous system.
    Pytel P; Lukas RV
    Arch Pathol Lab Med; 2009 Jul; 133(7):1062-77. PubMed ID: 19642733
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
    Louis DN; Perry A; Reifenberger G; von Deimling A; Figarella-Branger D; Cavenee WK; Ohgaki H; Wiestler OD; Kleihues P; Ellison DW
    Acta Neuropathol; 2016 Jun; 131(6):803-20. PubMed ID: 27157931
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Atypical teratoid/rhabdoid tumors of childhood].
    Mitrofanova AM; Konovalov DM; Kisliakov AN; Roshchin VIu; Abramov DS
    Arkh Patol; 2013; 75(5):36-42. PubMed ID: 24341231
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Atypical teratoid/rhabdoid tumor (AT/RT)].
    Biernat W
    Pol J Pathol; 2001; 52(4 Suppl):139-40. PubMed ID: 11987601
    [No Abstract]   [Full Text] [Related]  

  • 46. Atypical teratoid rhabdoid tumor in childhood, 15 cases of a single institute experience.
    Al-Hussaini M; Dissi N; Al-Jumaily U; Swaidan M
    Turk Patoloji Derg; 2014; 30(1):43-54. PubMed ID: 24448710
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Items (tumors) worthy of special mention in the proposed new WHO histological classification of tumors of the central nervous system].
    Ishida Y
    No To Shinkei; 1994 Dec; 46(12):1127-32. PubMed ID: 7893529
    [No Abstract]   [Full Text] [Related]  

  • 48. The role of stem cells in pediatric central nervous system malignancies.
    Manoranjan B; Garg N; Bakhshinyan D; Singh SK
    Adv Exp Med Biol; 2015; 853():49-68. PubMed ID: 25895707
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Four Levels of Diagnosis in the Rare Pediatric Embryonal Tumor of the CNS Called Embryonal Tumor with Multilayered Rosettes.
    Frazier AA
    Radiographics; 2018; 38(2):524. PubMed ID: 29528833
    [No Abstract]   [Full Text] [Related]  

  • 50. Clinicopathological characteristics of atypical teratoid/rhabdoid tumor.
    Oka H; Scheithauer BW
    Neurol Med Chir (Tokyo); 1999 Jul; 39(7):510-7; discussion 517-8. PubMed ID: 10437379
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genomic Molecular Classification of CNS Malignancies.
    Spino M; Snuderl M
    Adv Anat Pathol; 2020 Jan; 27(1):44-50. PubMed ID: 31714292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunohistochemical analysis of INI1 protein in malignant pediatric CNS tumors: Lack of INI1 in atypical teratoid/rhabdoid tumors and in a fraction of primitive neuroectodermal tumors without rhabdoid phenotype.
    Haberler C; Laggner U; Slavc I; Czech T; Ambros IM; Ambros PF; Budka H; Hainfellner JA
    Am J Surg Pathol; 2006 Nov; 30(11):1462-8. PubMed ID: 17063089
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Embryonal tumor with multilayered rosettes: Two case reports with a review of the literature.
    Neelima R; Easwer HV; Kapilamoorthy TR; Hingwala DR; Radhakrishnan VV
    Neurol India; 2012; 60(1):96-9. PubMed ID: 22406791
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pathology and diagnosis of SMARCB1-deficient tumors.
    Margol AS; Judkins AR
    Cancer Genet; 2014 Sep; 207(9):358-64. PubMed ID: 25246033
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children.
    Kellie SJ; Wong CK; Pozza LD; Waters KD; Lockwood L; Mauger DC; White L
    Med Pediatr Oncol; 2002 Sep; 39(3):168-74. PubMed ID: 12210445
    [TBL] [Abstract][Full Text] [Related]  

  • 56. LIN28A immunoreactivity is a potent diagnostic marker of embryonal tumor with multilayered rosettes (ETMR).
    Korshunov A; Ryzhova M; Jones DT; Northcott PA; van Sluis P; Volckmann R; Koster J; Versteeg R; Cowdrey C; Perry A; Picard D; Rosenblum M; Giangaspero F; Aronica E; Schüller U; Hasselblatt M; Collins VP; von Deimling A; Lichter P; Huang A; Pfister SM; Kool M
    Acta Neuropathol; 2012 Dec; 124(6):875-81. PubMed ID: 23161096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Central Nervous System-type Neuroepithelial Tumors and Tumor-like Proliferations Developing in the Gynecologic Tract and Pelvis: Clinicopathologic Analysis of 23 Cases.
    Murdock T; Orr B; Allen S; Ibrahim J; Sharma R; Ronnett BM; Rodriguez FJ
    Am J Surg Pathol; 2018 Nov; 42(11):1429-1444. PubMed ID: 30074494
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incidence, Trends, and Survival of Children With Embryonal Tumors.
    Tulla M; Berthold F; Graf N; Rutkowski S; von Schweinitz D; Spix C; Kaatsch P
    Pediatrics; 2015 Sep; 136(3):e623-32. PubMed ID: 26304823
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Central nervous system tumors in patients under three years of age: treatment results of a single institute.
    Varan A; Akalan N; Söylemezoğlu F; Zorlu F; Yalçin B; Akyüz C; Kutluk T; Büyükpamukçu M
    Pediatr Neurosurg; 2006; 42(2):89-94. PubMed ID: 16465077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New immunohistochemical markers in the evaluation of central nervous system tumors: a review of 7 selected adult and pediatric brain tumors.
    Takei H; Bhattacharjee MB; Rivera A; Dancer Y; Powell SZ
    Arch Pathol Lab Med; 2007 Feb; 131(2):234-41. PubMed ID: 17284108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.